How NHS worked with Sonde
Royal Papworth Hospital in Cambridge, UK and Cambridge University under direction of Professor Andres Floto started running Project Breathe in 2019. Project Breathe is evaluating whether home monitoring can improve the way we care for people with CF. Sonde is teaming up with Project Breathe to provide Sonde’s respiratory app for daily voice sample collection. In this phase, vocal biomarkers will be analyzed by the joint research team without using the scores clinically, to evaluate their potential to further improve care management. 100-200 people with CF will get access to the Sonde app and submit daily voice samples in addition to their established home monitoring under Project Breathe.
The Benefits
100-200 participants from Royal Papworth Cystic Fibrosis clinic
Add-on to an ongoing initiative that collects daily telemetry from patients
Goal is to demonstrate potential for early detection of the onset of pulmonary exacerbations
Vocal biomarkers could provide a unique monitoring approach in cystic fibrosis because:
High frequency of data collection (daily) for extended periods (12+ months)
Simple and non-invasive:
Captures patient’s voice only
No equipment needed:
Uses patient’s own smartphone
